Table 2.
Abnormal biological and urinary findings at the first attack
| Abnormal findings | Patients/population (%) |
Total, n/N (%) | Median (rangea) | ||
|---|---|---|---|---|---|
| CoR 11, n (%) |
InR 34, n (%) |
P | |||
| Biological | |||||
| eGFR <30 ml/min per 1.73 m2 | 2 (18) | 20 (59) | 0.04 | 22/46 (48) | 30.6 (4.9–62.8) |
| Hypokalemia (mmol/l) | 2 (18) | 8 (24) | 1 | 10/46 (22) | 3.8 (2.7–4.6) |
| Hypophosphatemia (mmol/l) | 3 (27) | 7 (21) | 0.66 | 10/45 (22) | 1.13 (0.64–1.75) |
| Acidosis (bicarbonates mmol/l) | 6 (55) | 18 (23) | 25/45 (56) | 20.5 (12–28) | |
| Biological inflammatory syndrome | MD | MD | MD | 41/45 (91) | |
| CRP (mg/l) | MD | MD | MD | 30/44 (68) | 25.8 (2–161) |
| ESR (mm/h) | MD | MD | MD | 24/32 (75) | 73 (22–128) |
| Anemia (g/dl) | 9 (82) | 25 (74) | 0.70 | 35/46 (76) | 10.5 (6.9–14.5) |
| Lymphopenia (/mm3) | 1 (9) | 4 (12) | 0.82 | 5/43 (12) | 2400 (1000–6410) |
| Hyperleukocytosis (/mm3) | 3 (27) | 5 (15) | 0.48 | 8/43 (19) | 8870 (4540–19,960) |
| Hypereosinophilia (/mm3) | 0 (0) | 0 (0) | 0/39 (0) | 341 (40–644) | |
| Urinary | |||||
| Increase of β2m (mg/l) | MD | MD | MD | 28/28 (100) | 19.3 (1.05–72.2) |
| Proteinuria (mg/mmol) | 10 (91) | 30 (88) | 1 | 41/46 (89) | 93 (8–279.8) |
| Normoglycemic glycosuria | 8 (73) | 25 (74) | 0.52 | 33/37 (89) | |
| Aseptic leukocyturia | 9 (82) | 18 (53) | 0.26 | 28/41 (68) | |
| Hematuria | 2 (18) | 6 (18) | 1 | 8/41 (20) | |
CoR, complete recovery; eGFR, estimated glomerular filtration rate; ESR, erythrocyte sedimentation rate; InR, incomplete recovery; MD, missing data; β2m, β2-microgluobulin.
a
Range from minimum to maximum.